MBRX — Moleculin Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Moleculin Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	15.2	70.9	43.1	23.6	4.28
Net Total Receivables	0.164	0.496	1.05	1.52	0.015
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17.2	72.5	45.6	26.3	5.19
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.685	0.445	0.678	0.796	0.583
Net Intangible Assets
Total Assets	29	84.1	57.4	38.2	16.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.92	3.62	4.82	6.82	5.36
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.3	5.1	5.23	12.1	10.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.8	79	52.2	26.1	5.98
Total Liabilities & Shareholders' Equity	29	84.1	57.4	38.2	16.9
Total Common Shares Outstanding